Logo Logo Logo Logo Logo
  • COMPANY
    • About Us
    • Management team
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Main Investors
    • Contact Us
  • SCIENCE
    • Formulation Discovery
      • OPTIREACH Technology
      • Antibody Fragment Technology
    • Intellectual Property
  • PIPELINE
    • Overview
    • OCS-01 Diabetic Macular Edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye
  • NEWS
    • Press releases
    • Articles
  • CAREERS

  • COMPANY

    • About Us
    • Management team
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Main Investors
    • Contact Us

  • SCIENCE

    • Formulation Discovery

      • OPTIREACH Technology
      • Antibody Fragment Technology
    • Intellectual Property

  • PIPELINE

    • Overview
    • OCS-01 Diabetic Macular Edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye

  • NEWS

    • Press releases
    • Articles
  • CAREERS
Contact us

Oculis Switzerland
Corporate Headquarters
EPFL Innovation Park Building D
Route J-D. Colladon
1015 Lausanne
Switzerland

+41 21 711 3970

 

info@oculis.com

Copyright © 2020 Oculis SA.

    © Oculis – Private policy

    © L’autreagence 2019